Kaempferol can enhance the sensitivity of pancreatic cancer cells to targeted drugs by inhibiting PI3K/AKT signaling pathway and epidermal growth factor receptor [30]. The gene discussed is EGFR; the disease is familial pancreatic carcinoma.